Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Update

Rockwell Medical, Inc. (NASDAQ:RMTI) saw a significant decline in short interest in February. As of February 15th, there was short interest totalling 438,800 shares, a decline of 13.0% from the January 31st total of 504,200 shares. Based on an average daily volume of 414,700 shares, the days-to-cover ratio is currently 1.1 days. Currently, 1.6% of the shares of the stock are sold short.

Hedge Funds Weigh In On Rockwell Medical

Several institutional investors and hedge funds have recently made changes to their positions in RMTI. Beacon Financial Advisory LLC purchased a new stake in Rockwell Medical during the third quarter valued at about $98,000. Concurrent Investment Advisors LLC purchased a new stake in Rockwell Medical during the 3rd quarter valued at about $40,000. Verus Capital Partners LLC bought a new position in Rockwell Medical during the 3rd quarter worth approximately $51,000. Corsair Capital Management L.P. purchased a new position in Rockwell Medical in the 3rd quarter worth approximately $298,000. Finally, Walleye Capital LLC bought a new stake in Rockwell Medical in the third quarter valued at approximately $435,000. Institutional investors own 23.31% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on RMTI shares. HC Wainwright reaffirmed a “buy” rating and issued a $7.00 target price on shares of Rockwell Medical in a research note on Monday, December 23rd. StockNews.com lowered shares of Rockwell Medical from a “buy” rating to a “hold” rating in a report on Friday, December 20th. RODMAN&RENSHAW raised shares of Rockwell Medical to a “strong-buy” rating in a report on Thursday, November 14th. Finally, Rodman & Renshaw initiated coverage on Rockwell Medical in a research note on Thursday, November 14th. They issued a “buy” rating and a $5.00 target price on the stock.

Rockwell Medical Stock Up 1.3 %

Shares of NASDAQ RMTI opened at $1.62 on Friday. The stock has a market capitalization of $52.36 million, a P/E ratio of -32.40 and a beta of 1.55. Rockwell Medical has a one year low of $1.35 and a one year high of $5.15. The firm’s 50 day simple moving average is $1.96 and its two-hundred day simple moving average is $2.71. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.